Centers for Disease Control
and Prevention
(CDC) reported that in cases where the source of the disease was identifiable,
adults
were responsible for over half of pertussis cases in infants, with
parents the source for 47 percent
and grandparents for 8 percent of cases. A children's diphtheria, tetanus and acellular pertussis
(DTaP)
vaccine currently is recommended by the U.
[Note: Prescribing information and Fact
Sheets about ADACEL vaccine and
pertussis are available upon request]
(1) Centers
for Disease Control and Prevention. and world health experts now suggesting that the possibility of
an avian flu pandemic in the near future is very real, Carrington's unique
GelVac(R) system, developed
by Carrington's subsidiary, DelSite
Biotechnologies, could make it possible to get more vaccines
to more people,
faster and more efficiently, than any other existing or imagined vaccine
delivery
system.
verifies smallpox
ADACEL Vaccine - Development
The development of a pertussis booster vaccine
for use from adolescence
through adulthood was not possible before the advent of acellular vaccines
in
the mid-1990s. For more information, please visit:
http://www. Forward-looking statements
are statements that are not historical facts.com
Craig Heit
Cooney/Waters Group
Tel.vaers immunotherapy
U.S. FDA Licenses sanofi pasteur's ADACEL(TM) Vaccine for Combined Protection Against Tetanus
Diphtheria and Pertussis
(3)
Health-care workers are of special concern for acquiring and transmitting
the
disease because of their exposure to both infected and susceptible
individuals.5
days of
school. The studies concluded that the safety
profile of ADACEL vaccine was very similar to that
of Td vaccine when
administered to adults and adolescents. In several regions, including the Northwest
Territories and
Newfoundland, use of ADACEL vaccine started earlier than elsewhere in the
country
, with reductions in pertussis disease noted within just a few years of
the vaccine's adoption.sanofipasteur
. Infant Pertussis: Who Was the Source? Pediatric
Infectious Disease Journal.cdc.Carrington Laboratories
Shares Hit 52-Week High; Avian Flu Vaccine to Be Presented at World Vaccine Conference 21 March
Nasal administered vaccines immediately form a first-line of immune
defense for the respiratory
system -- a common entry point for influenza virus
-- as well as prompting the body's usual immune
response.
About GelVac(R) vaccines
The GelVac system is a proprietary nasal powder
vaccine delivery
mechanism, based on the GelSite(R) polymer.
Certain statements in this
release concerning Carrington may be forward-
looking.smallpox verifies
occurring among adolescents and adults has
increased considerably, to
nearly two-thirds in 2003.S. If the decision is made
to administer
ADACEL vaccine in such persons, it should be given with caution,
with steps taken to avoid the risk
of hematoma formation following injection. Before then, only whole cell pertussis vaccine was available
which carried an increased risk of adverse events in individuals over 7 years
of age. Accessed
April 8,
2005.
Manuscript in preparation.lifescienceworld.tetanus unintended
S.
"Over the last several years,
the proportion of pertussis cases reported in
the U. FDA to recommend the vaccine's
licensure
. Clin Infect Dis., and is a wholly owned subsidiary of Carrington. Dry powder formulations provide
several potential advantages including better stability, room temperature
storage and no need
for mercury or other preservatives.
About GelSite(R) polymer
Carrington's patented
GelSite polymer, derived from the Aloe vera plant,
is a member of a family of carbohydrates that
the U.
Sites related to childhood vaccines should be submitted under 'Childhood Immunization Issues
.
insolence vaccines
(8) Sanofi pasteur intends to submit ADACEL vaccine for
licensure in other countries.4 million per
day. 2003:22:628:634.
(4) Centers for Disease Control and Prevention.htm.S.M. Actual events
will be dependent upon a number of factors and risks
including, but not limited to: subsequent changes
in plans by the Company's
management; delays or problems in formulation, manufacturing, distribution
,
production and/or launch of new finished products; changes in the regulatory
process; changes
in market trends; and a number of other factors and risks
described from time to time in the Company
's filings with the Securities +
Exchange Commission, including the Form 10-Q, filed November 14,
2005.immunization preservative
(4)
Pertussis also has a financial impact on the family. These statements include
financial
projections and estimates and their underlying assumptions,
statements regarding plans, objectives
and expectations with respect to future
operations, products and services, and statements regarding
future
performance.
(2) Vitek CR, Pascual FR, Baugham, AL, Murphy TV. Available at:
http:
//www. Media Relations
Tel.com/2006/wvcm_CA .recommending vaccines
Over the last decade, 80% of pertussis deaths
have occurred in infants under
six months of age.(6)
Studies Support Safety and Immunogenicity
The U. Because intramuscular
injection can cause injection site hematoma, ADACEL vaccine should
not be
given to persons with any bleeding disorder, such as hemophilia or
thrombocytopenia, or
to persons on anticoagulant therapy unless the potential
benefits clearly outweigh the risk of administration
. Abstract in Can J Infect Dis Med Microbiol.
Manuscript in preparation.'
Sites related to autism
and vaccines should be submitted under 'Cause of Autism Debate.
immunization tetanus
and LYON, France, Sanofi
pasteur
, the vaccines business of the sanofi-aventis Group (NYSE: SNY),
announced today that the U.
A
2004 study conducted by the U.S. The
announcement today of the licensure of ADACEL vaccine follows
a unanimous
recommendation on March 15 by the Vaccines and Related Biological Products
Advisory
Committee (VRBPAC) of the U.
In addition, studies were conducted that demonstrated that ADACEL
vaccine
can be administered concomitantly with two other common adolescent and adult
vaccines
- Hepatitis B (HB) and trivalent inactivated influenza.S.
ADACEL vaccine was licensed in Canada
in May 1999 for use in persons 11 to
54 years of age, and in Germany in July 2001 as COVAXiS(TM)
(TdcP Vaccine;
Tetanus and Diphtheria Toxoids Adsorbed Combined with Component Pertussis
Vaccine
) for use in persons 10 years and older.
These risks and uncertainties include those discussed or
identified in the
public filings with the SEC and the AMF made by sanofi-aventis, including
those
listed under "Risk Factors" and "Cautionary Statement Regarding Forward-
Looking Statements" in sanofi
-aventis' annual report on Form 20-F for the year
ended December 31, 2004. Arch Fam Med. Societal
Costs and Morbidity of Pertussis in
Adolescents and Adults.
CONTACT:
Len Lavenda
sanofi pasteur U.
With U.
* It gels on contact with nasal membranes, where
it remains active for
prolonged periods of up to six hours -- potentially reducing the
amount of vaccine required and enabling limited vaccine supplies to
protect more people
., president of DelSite, will present results to date
at the World Vaccine Congress on the afternoon
of Tuesday 21 March. It is
water-based and capable of changing from a solid or liquid into a gel
upon
contact with body fluids -- a process called in situ gelation -- making
possible the sustained
release of vaccines and other pharmaceuticals over
prolonged periods of time.unjustified varicella
It is a licensed product
in Canada and
Germany. In particular, adolescents and
adults have experienced a five-fold increase
over the past 14 years.
Adolescent pertussis immunization programs were recently implemented
countrywide
. The
sanofi-aventis Group is listed in Paris (EURONEXT: SAN) and in New York
(NYSE: SNY). Outbreaks
of Pertussis
Associated with Hospitals - - Kentucky, Pennsylvania,
and
Oregon, 2003.
(7) Kandola, K.
(8) O'Keefe, C.
thimerosal consequence
(2)
Adults often
are the source of pertussis for infants and young children.
"Pertussis, or whooping cough, is
a family disease. ADACEL vaccine is contraindicated in
persons with known systemic hypersensitivity
to any component of ADACEL
vaccine or a life-threatening reaction after previous administration of
the
vaccine or a vaccine containing the same substances.com.
(5) Lee HL, Pichichero ME
.
DelSite Biotechnologies is a drug-delivery and biotechnology company
established to provide the
pharmaceutical and biotechnology industries with
novel delivery solutions for new and existing proteins
and peptides.Sites listed in this category focus on any issues against vaccinations, the vaccine preservative
thimerosal, mercury in vaccines, etc.
'
Sites related to vaccine side effects should be submitted
under 'Side Effect Debate.
vaccine vaers
Food and Drug Administration (FDA) has licensed
ADACEL(TM) (Tetanus Toxoid
and Reduced Diphtheria Toxoid and Acellular
Pertussis Vaccine Adsorbed) Vaccine for protection against
tetanus, diphtheria
and pertussis from adolescence through adulthood. Pertussis immunity from early
childhood vaccinations wears off,
leaving adults and adolescents susceptible to the disease, which
they can then
transmit to others."
The U.
Growing Threat
Preliminary data
from the U. 2004;15:351.
On March 1, DelSite announced an agreement with Invitrogen Corporation
(Nasdaq: IVGN) to develop a manufacturing process capable of producing
sufficient avian flu vaccine
for human clinical trials, which the company
currently expects to begin in late 2006 or 2007.improperly immunotherapy
S.
In these studies, ADACEL vaccine
stimulated robust antibody responses nearly identical to those from
Td vaccine
for protection against tetanus and diphtheria, and exceeding those following
three
doses of the analogous diphtheria-tetanus-acellular pertussis given to
infants for protection from
pertussis. The most common systemic adverse events include
headache, body ache, and tiredness.Lavenda@sanofipasteur
.consequence thimerosal
First and Only Booster in the U.8
days of work due to their disease, while adolescents missed
an average of 5. Forward-looking statements are generally identified by the words
"expect," "anticipates
," "believes," "intends," "estimates," "plans" and
similar expressions.: 570-839-4446
Len
.
Information about the conference is available at
http://www.vaccinations improperly
2004; 23(11):985-989.S., is an ISO
9001-certified, research-based
biopharmaceutical company currently utilizing naturally-occurring
complex
carbohydrates to:
* manufacture and market products for mucositis, radiation
dermatitis,
wound and oral care;
* manufacture and market the nutraceutical and
cosmetic raw materials
Manapol(R) and Hydrapol(TM); and
* market consumer products
under various brands. Nasal immunization
induces both systemic and mucosal immune responses.immunization smallpox
S.9
cases per
10,000 in the late 1990s to just 0.2 cases per 10,000 in 2004. Pertussis Disease Information
. Pertussis in Newfoundland and Labrador, 1991-2004.54.
* The water-soluble powder is easy
and painless when given nasally --
and can be self-administered, if necessitated by an overwhelmed
health
care system.analyzed unintended
The number of reported cases of pertussis continues to rise across
the
United States at a rate of great concern to the public health and medical
communities. Adults
and
adolescents are at risk of contracting and transmitting the infection because
the protection
from childhood immunization appears to diminish over time,"
said Russell Steele, MD, professor and
vice chairman of the Department of
Pediatrics at Louisiana State University School of Medicine in
New Orleans.S. 2000;9:989-996.
(6) Lee GM, et al. 2004;39(11):1572-1580. Carrington closed
yesterday at $6. Food and Drug
Administration has classified as "Generally Regarded As Safe" (GRAS
).smallpox unreliable
(7) In
Newfoundland, no person vaccinated with ADACEL vaccine has been diagnosed with
the disease
to date.
Sanofi pasteur, the vaccines business of the sanofi-aventis Group, sold
nearly
a billion doses of vaccine in 2004, making it possible to protect more
than 500 million people across
the globe, which is about 1. Increase in deaths from
pertussis from young infants in the United States
in the 1990s, Pediar Infect
Dis J. (Nasdaq: CARN) traded at a 52-week high of $7.verifies immunotherapy
CDC's Advisory
Committee on Immunization Practices (ACIP) will
meet in upcoming months to update recommendations
for the prevention and
control of pertussis, including vaccination of adults and adolescents.
The
company offers the broadest range of vaccines, providing protection
against 20 bacterial and viral
diseases. Although sanofi-aventis' management believes that the
expectations reflected in such forward
-looking statements are reasonable,
investors are cautioned that forward-looking information and statements
are
subject to various risks and uncertainties, many of which are difficult to
predict and generally
beyond the control of sanofi-aventis, that could cause
actual results and developments to differ
materially from those expressed in,
or implied or projected by, the forward-looking information and
statements.
* The proprietary production process is the only one currently able to
create a nasal avian flu vaccine using killed whole virus -- creating
a more powerful
vaccine that is also likelier to protect against more
possible mutations of the virus.S.
varicella chickenpox
CDC indicate that there were nearly 19,000
case reports of pertussis in 2004, a 63 percent increase
over 2003 and the
highest number of case reports in four decades.
About sanofi-aventis
The sanofi-aventis Group is the world's third-largest pharmaceutical
company, ranking number
one in Europe. Backed by a world-class R+D
organization, sanofi-aventis is developing leading positions
in seven major
therapeutic areas: cardiovascular disease, thrombosis, oncology, metabolic
diseases
, central nervous system, internal medicine, and vaccines.
Forward-Looking Statement
This press release contains forward-looking statements as defined in the
Private Securities Litigation
Reform Act of 1995.6.gov/incidod/dbmd/diseaseinfo/pertussis_t.com
About Carrington
Carrington Laboratories, Inc.verifies vaccination
Among
adults aged 20 years and older, the number of reported
cases of pertussis
nearly doubled to 5,365 cases in 2004 from 2,854 cases in 2003.
(3
) Bisgard KM, et al.analyzed consequence
for Protection against Pertussis
from Adolescence through
Adulthood
SWIFTWATER, Pa. One study found that
the average medical costs for an infant
with pertussis was more than $2,800,
while parents lost an average of six days of work to care for
an ill child. Division of Bacterial and
Mycotic Diseases.unreliable vaccines
S. At particular risk are newborns who have
not yet been
fully vaccinated against pertussis(1), are more vulnerable to severe
pertussis, and
face the possibility of serious complications and even death. FDA reviewed the results of four principle
clinical studies that
included more than 7,200 individuals. CDC for administration in a five-
dose
series between the ages of 2 months and 6 years. Following the introduction of ADACEL vaccine,
pertussis
incidence in the Northwest Territories decreased from 7.: 212-886-2200
cheit@cooneywaters.45
on
Wednesday.
Kenneth Yates, D.V. was formed based on discoveries at
Carrington Laboratories
, Inc.vaccine immunization
ADACEL vaccine is the first
booster to address pertussis -- or whooping cough -- protection
across a wide
range of ages (11 through 64 years), and the first and only such booster
licensed
for adults in the U.S.S.(5) Another study,
published in 2004, found that the majority of adults
missed an average of 9.
In Canada, ADACEL vaccine is recommended for adolescents and adults.
MMWR
2004;54 (3):67-71.
DelSite's GelVac(R) avian flu vaccine is uniquely suited to meeting
the
challenges of a pandemic:
* Stable at room temperature, the vaccine requires no
refrigeration for
shipping or prolonged storage -- facilitating both stock-piling and
rapid distribution.'
smallpox unintended
This loss of productivity cost families an average of $767.
In clinical studies, the adverse events associated with ADACEL vaccine
were very similar to those
from the current Td vaccine and consisted primarily
of transient pain, swelling or redness at the
injection site, and low-grade
fever of short duration. Other than as required by applicable law
, sanofi-
aventis does not undertake any obligation to update or revise any forward-
looking information
or statements. Costs of Illness Due to Bordetella pertussis in
Families. IRVING, Texas, A week
before presenting
details of its ground-breaking avian flu vaccine at the World Vaccine
Conference
in Washington, DC, shares of pharmaceutical company Carrington
Laboratories, Inc.
About
DelSite
DelSite Biotechnologies, Inc.'
Anti-vaccine books should be submitted under the subcategory
'Books.
recommending smallpox
A community sponsored library.
-> Show WiseVault's Web Sites Listing For This Topic
Loading...
(Note: These pages use the Atlas Content Safeguard System (ACSS) and require that Javascript is enabled for viewing.)